A severe neurodegenerative disease with Lewy bodies and a mutation in the glucocerebrosidase gene

被引：2

作者：

Sipila, Jussi O. T. ^{[1
,2
]}

Kytovuori, Laura ^{[3
,4
,5
,6
]}

Rauramaa, Tuomas ^{[7
]}

Rauhamaa, Hugo ^{[3
,4
,5
,6
]}

Kaasinen, Valtteri ^{[1
,8
]}

Majamaa, Kari ^{[3
,4
,5
,6
]}

机构：

[1] Univ Turku, Clin Neurosci, Turku, Finland

[2] Siun Sote North Karel Cent Hosp, Dept Neurol, Joensuu, Finland

[3] Oulu Univ Hosp, Res Unit Clin Med, Oulu, Finland

[4] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland

[5] Univ Oulu, Oulu, Finland

[6] Oulu Univ Hosp, Neuroctr, Neurol, Oulu, Finland

[7] Univ Eastern Finland, Inst Clin Med, Unit Pathol, Kuopio, Finland

[8] Turku Univ Hosp, Neuroctr, Turku, Finland

来源：

NPJ PARKINSONS DISEASE | 2023年 / 9卷 / 01期

关键词：

PARKINSONS-DISEASE; GBA MUTATIONS; SURVIVAL; DEMENTIA;

D O I：

10.1038/s41531-023-00501-4

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Several heterozygous variants of the glucocerebrosidase gene (GBA1) have been reported to increase the risk of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). GBA1-associated PD has been reported to be more severe than idiopathic PD, and more deleterious variants are associated with more severe clinical phenotypes. We report a family with a heterozygous p.Pro454Leu variant in GBA1. The variant was associated with a severe and rapidly progressive neurodegenerative disease with Lewy bodies that were clinically and pathologically diverse. Pathogenicity prediction algorithms and evolutionary analyses suggested that p.Pro454Leu is deleterious.

引用

页数：6

共 50 条

[41] Parkinson's disease in a patient with multiple sclerosis and heterozygous glucocerebrosidase gene mutation
Delalic, Sentilija
Rus, Tomaz
Ledinek, Alenka Horvat
Kojovic, Maja
Georgiev, Dejan
CLINICAL PARKINSONISM & RELATED DISORDERS, 2020, 3
[42] The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders
Velayati, Arash
Yu, W. Haung
Sidransky, Ellen
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2010, 10 (03) : 190 - 198
[43] The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders
Arash Velayati
W. Haung Yu
Ellen Sidransky
Current Neurology and Neuroscience Reports, 2010, 10 : 190 - 198
[44] MUTATION ANALYSIS OF THE GLUCOCEREBROSIDASE GENE IN ROMANIAN PATIENTS
Drugan, C.
Drugan, T.
Olteanu, I.
Grigorescu-Sido, P.
Caillaud, C.
CLINICAL THERAPEUTICS, 2008, 30 : S101 - S101
[45] Severe neurodegenerative disease in brothers with homozygous mutation in POLR1A
Kara, Bulent
Koroglu, Cigdem
Peltonen, Karita
Steinberg, Ruchama C.
Genc, Hulya Maras
Holtta-Vuori, Maarit
Guven, Ayse
Kanerva, Kristiina
Kotil, Tugba
Solakoglu, Seyhun
Zhou, You
Olkkonen, Vesa M.
Ikonen, Elina
Laiho, Marikki
Tolun, Aslihan
EUROPEAN JOURNAL OF HUMAN GENETICS, 2017, 25 (03) : 315 - 323
[46] Severe neurodegenerative disease in brothers with homozygous mutation in POLR1A
Bülent Kara
Çiğdem Köroğlu
Karita Peltonen
Ruchama C Steinberg
Hülya Maraş Genç
Maarit Hölttä-Vuori
Ayşe Güven
Kristiina Kanerva
Tuğba Kotil
Seyhun Solakoğlu
You Zhou
Vesa M Olkkonen
Elina Ikonen
Marikki Laiho
Aslıhan Tolun
European Journal of Human Genetics, 2017, 25 : 315 - 323
[47] Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with lewy bodies
Baba, M
Nakajo, S
Tu, PH
Tomita, T
Nakaya, K
Lee, VMY
Trojanowski, JQ
Iwatsubo, T
AMERICAN JOURNAL OF PATHOLOGY, 1998, 152 (04): : 879 - 884
[48] Nuclear bodies in neurodegenerative disease
Woulfe, John
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2008, 1783 (11): : 2195 - 2206
[49] Lewy bodies in the amygdala:: α-Synuclein expression is increased in specific neurodegenerative diseases
Popescu, A
Lippa, CF
NEUROLOGY, 2001, 56 (08) : A177 - A178
[50] Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
Kurt A. Jellinger
npj Parkinson's Disease, 8

← 1 2 3 4 5 →